Hospira Recalls 30-mL 0.5% Bupivacaine Hydrochloride
Fri, 24 Apr 2015 00:00:00 -0400
Hospira Inc. on April 23 (PDF) announced the recall of lot 38-515-DK of preservative-free 0.5% bupivacaine hydrochloride injection, 30 mL, because a customer found orange and black particles floating in the solution and embedded in the glass teartop vial.
Ivabradine Approved for Stable Chronic Heart Failure
Thu, 16 Apr 2015 00:00:00 -0400
and Amgen on April 15 announced the approval of ivabradine oral tablets to reduce the risk of hospitalization in certain patients with stable chronic heart failure.
Pharmacist-Based Activities Associated With Better Dabigatran Adherence
Tue, 14 Apr 2015 00:00:00 -0400
In an article published in today's Journal of the American Medical Association, researchers reported that patient selection and monitoring by dedicated pharmacists, but not patient education, were associated with better adherence to dabigatran therapy.
Timing Critical in Hypertension Treatment, Study Finds
Mon, 13 Apr 2015 00:00:00 -0400
A recently published report indicates that delaying treatment intensification and follow-up can prove deadly for patients with hypertension.
Hospitals Partner With SNFs to Reduce Readmissions
Some hospitals are reaching out to local skilled nursing facilities (SNFs) as part of an effort to reduce 30-day readmission rates.